These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29332199)

  • 1. Analysis of the data on pregnancy and lactation provided by patient information leaflets of anti-rheumatic drugs in Argentina.
    Sabando MO; Saavedra MA; Sequeira G; Kerzberg E
    Rheumatol Int; 2018 Apr; 38(4):669-673. PubMed ID: 29332199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.
    Götestam Skorpen C; Hoeltzenbein M; Tincani A; Fischer-Betz R; Elefant E; Chambers C; da Silva J; Nelson-Piercy C; Cetin I; Costedoat-Chalumeau N; Dolhain R; Förger F; Khamashta M; Ruiz-Irastorza G; Zink A; Vencovsky J; Cutolo M; Caeyers N; Zumbühl C; Østensen M
    Ann Rheum Dis; 2016 May; 75(5):795-810. PubMed ID: 26888948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand.
    Phueanpinit P; Pongwecharak J; Krska J; Jarernsiripornkul N
    Int J Clin Pharm; 2016 Feb; 38(1):25-9. PubMed ID: 26582482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current aspects of antirheumatic therapy in pregnancy planning, during pregnancy and breastfeeding].
    Häfeli C; Förger F
    Z Rheumatol; 2021 Oct; 80(8):716-725. PubMed ID: 34581874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antirheumatic drugs in pregnancy and lactation.
    Temprano KK; Bandlamudi R; Moore TL
    Semin Arthritis Rheum; 2005 Oct; 35(2):112-21. PubMed ID: 16194696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient information leaflets (PILs) for UK randomised controlled trials: a feasibility study exploring whether they contain information to support decision making about trial participation.
    Gillies K; Huang W; Skea Z; Brehaut J; Cotton S
    Trials; 2014 Feb; 15():62. PubMed ID: 24548781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of user-tested Thai patient information leaflets for non-steroidal anti-inflammatory drugs: Effect on patients' knowledge.
    Jarernsiripornkul N; Phueanpinit P; Pongwecharak J; Krska J
    PLoS One; 2019; 14(1):e0210395. PubMed ID: 30625196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation.
    Levy RA; de Jesús GR; de Jesús NR; Klumb EM
    Autoimmun Rev; 2016 Oct; 15(10):955-63. PubMed ID: 27490204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation.
    Janssen NM; Genta MS
    Arch Intern Med; 2000 Mar; 160(5):610-9. PubMed ID: 10724046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient information leaflets--helpful guidance or a source of confusion?
    Bjerrum L; Foged A
    Pharmacoepidemiol Drug Saf; 2003; 12(1):55-9. PubMed ID: 12616848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers.
    Viktil KK; Engeland A; Furu K
    Scand J Rheumatol; 2012 May; 41(3):196-201. PubMed ID: 22401133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimisation of antirheumatic drug treatment in pregnancy.
    Ostesen M
    Clin Pharmacokinet; 1994 Dec; 27(6):486-503. PubMed ID: 7882637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, validation and user-testing of pictogram-based patient information leaflets for tuberculosis.
    Shrestha A; Rajesh V; Dessai SS; Stanly SM; Mateti UV
    Pulm Pharmacol Ther; 2018 Aug; 51():26-31. PubMed ID: 29807128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety of rheumatic disease drugs at childbearing age].
    Zrour-Hassen S; Jguirim M; Aouam K; Korbaa W; Younes M; Bejia I; Touzi M; Bergaoui N
    Therapie; 2010; 65(5):465-73. PubMed ID: 21144482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of instructions in patient information leaflets for the use of intranasal corticosteroid sprays: an observational study.
    Rollema C; van Roon EM; Schilder AG; de Vries TW
    BMJ Open; 2019 Jan; 9(1):e026710. PubMed ID: 30647049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention strategies are routinely communicated to potential trial participants but often differ from what was planned in the trial protocol: an analysis of adult participant information leaflets and their corresponding protocols.
    Murphy E; Gillies K; Shiely F
    Trials; 2024 Jun; 25(1):372. PubMed ID: 38858790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paternal safety of anti-rheumatic medications.
    Bermas BL
    Best Pract Res Clin Obstet Gynaecol; 2020 Apr; 64():77-84. PubMed ID: 31727565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When describing harms and benefits to potential trial participants, participant information leaflets are inadequate.
    Cuddihy L; Howick J; Murphy E; Shiely F
    Trials; 2024 May; 25(1):292. PubMed ID: 38693579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient information leaflets for antidepressants: are patients getting the information they need?
    Haw C; Stubbs J
    J Affect Disord; 2011 Jan; 128(1-2):165-70. PubMed ID: 20656359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of anti-rheumatic drugs for rheumatoid arthritis in pregnancy and lactation.
    Ngian GS; Briggs AM; Ackerman IN; Van Doornum S
    Int J Rheum Dis; 2016 Sep; 19(9):834-43. PubMed ID: 27125255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.